Drug Profile
PTL 03001
Alternative Names: Deslorelin - PeptechLatest Information Update: 22 Mar 2007
Price :
$50
*
At a glance
- Originator Peptech
- Class
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 17 Jul 2001 This compound is still in active development
- 18 Dec 1997 Preclinical development for Prostate cancer in Australia (Intralesional)